The Deci Bio Interview with Carl Schulhammer 🧫| The Biotech Voyager EP017
Carl Schulhammer from DeciBio just spent two days at one of the biggest biotech conferences of the year and came on to break down what he saw. From where the big money is flowing, to why more doctors still don't know about cell therapies that already exist, to why South Korea might be quietly building the next big hub for drug development, this is a ground-level read on where the industry actually stands. New episodes every Tuesday and Thursday at 11:00 AM 🚀
▶︎
Where to Invest Right Now: Top AI, Regional Bank & Biotech Stocks
▶︎
Ep49 | S03 Ep07 | Dave Ulrich Father of Modern HR | Future of CHRO: From HR Ops to Global Leadership
▶︎
The Future of Myeloma: Screening, Smoldering Strategies, CAR T vs Transplant, and MRD-Guided Care
▶︎
The REAL Cause of Dementia Men & Women NEED To Know
▶︎
Geopolitical Alpha with Marko Papic
▶︎
Los Angeles about to Lose a Large Number of Restaurants | GianCarlo Pagani | Roozbeh Farahanipour
▶︎
Keynote: After the AI Hype – What’s Real, and What’s Next - Richard Campbell - 2026
▶︎
The Chokepoints Changing Global Shipping Forever with Sal Mercogliano | TGS 227
▶︎
AI Agents Full Course 2026: Master Agentic AI (2 Hours)
▶︎
Justin Wolfers on the economic absurdities of Trump's America | That's Business with Alan Kohler
▶︎
NATO’s European Test: Ukraine, Russia and the Future of the Alliance
▶︎
Politics Chat, July 14, 2026
▶︎
In Conversation With Nominal's Cameron McCord
▶︎
What Americans Need to Understand About China | The Ezra Klein Show
▶︎
Dr. Glen Jeffery: Using Red Light to Improve Your Health & the Harmful Effects of LEDs
▶︎
JPL x Ethan Peck | NXT in Space: Episode 1
▶︎
RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source
▶︎
Is the war about to escalate? │ Robert Pape │ The World Podcast
▶︎
Digital Asset Treasuries Under Pressure, IMF Warns of Tokenization Risks | Bloomberg Crypto 4/7/2026
▶︎